Annual Shareholders Equity
$212.26 M
-$73.30 M-25.67%
31 December 2023
Summary:
Anika Therapeutics annual stockholders equity is currently $212.26 million, with the most recent change of -$73.30 million (-25.67%) on 31 December 2023. During the last 3 years, it has fallen by -$60.13 million (-22.08%). ANIK annual shareholders equity is now -26.39% below its all-time high of $288.38 million, reached on 31 December 2019.ANIK Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$179.86 M
-$30.47 M-14.49%
30 September 2024
Summary:
Anika Therapeutics quarterly stockholders equity is currently $179.86 million, with the most recent change of -$30.47 million (-14.49%) on 30 September 2024. Over the past year, it has dropped by -$90.62 million (-33.50%). ANIK quarterly shareholders equity is now -38.76% below its all-time high of $293.69 million, reached on 31 March 2020.ANIK Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -25.7% | -33.5% |
3 y3 years | -22.1% | -38.0% |
5 y5 years | -19.5% | -36.1% |
ANIK Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -26.1% | at low | -38.0% | at low |
5 y | 5 years | -26.4% | at low | -38.8% | at low |
alltime | all time | -26.4% | +4145.3% | -38.8% | +3897.0% |
Anika Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $179.86 M(-14.5%) |
June 2024 | - | $210.34 M(+0.9%) |
Mar 2024 | - | $208.54 M(-1.8%) |
Dec 2023 | $212.26 M(-25.7%) | $212.26 M(-21.5%) |
Sept 2023 | - | $270.49 M(-1.3%) |
June 2023 | - | $274.01 M(-1.3%) |
Mar 2023 | - | $277.59 M(-2.8%) |
Dec 2022 | $285.56 M(-0.5%) | $285.56 M(+0.2%) |
Sept 2022 | - | $284.94 M(-0.4%) |
June 2022 | - | $286.15 M(+0.1%) |
Mar 2022 | - | $285.79 M(-0.5%) |
Dec 2021 | $287.08 M(+5.4%) | $287.08 M(-1.0%) |
Sept 2021 | - | $290.06 M(+1.1%) |
June 2021 | - | $286.80 M(+3.7%) |
Mar 2021 | - | $276.66 M(+1.6%) |
Dec 2020 | $272.40 M(-5.5%) | $272.40 M(-4.2%) |
Sept 2020 | - | $284.45 M(-1.4%) |
June 2020 | - | $288.44 M(-1.8%) |
Mar 2020 | - | $293.69 M(+1.8%) |
Dec 2019 | $288.38 M(+9.4%) | $288.38 M(+2.4%) |
Sept 2019 | - | $281.68 M(+12.2%) |
June 2019 | - | $250.95 M(-6.7%) |
Mar 2019 | - | $269.07 M(+2.1%) |
Dec 2018 | $263.61 M(+0.0%) | $263.61 M(+3.3%) |
Sept 2018 | - | $255.26 M(+3.5%) |
June 2018 | - | $246.60 M(-6.5%) |
Mar 2018 | - | $263.77 M(+0.1%) |
Dec 2017 | $263.49 M(+18.3%) | $263.49 M(+4.0%) |
Sept 2017 | - | $253.29 M(+3.7%) |
June 2017 | - | $244.14 M(+6.1%) |
Mar 2017 | - | $230.03 M(+3.3%) |
Dec 2016 | $222.77 M(+5.7%) | $222.77 M(+3.8%) |
Sept 2016 | - | $214.54 M(+5.0%) |
June 2016 | - | $204.42 M(+4.6%) |
Mar 2016 | - | $195.37 M(-7.3%) |
Dec 2015 | $210.85 M(+18.4%) | $210.85 M(+5.6%) |
Sept 2015 | - | $199.75 M(+4.8%) |
June 2015 | - | $190.57 M(+4.8%) |
Mar 2015 | - | $181.82 M(+2.1%) |
Dec 2014 | $178.10 M(+31.3%) | $178.10 M(+4.9%) |
Sept 2014 | - | $169.70 M(+4.5%) |
June 2014 | - | $162.39 M(+3.7%) |
Mar 2014 | - | $156.57 M(+15.4%) |
Dec 2013 | $135.63 M(+24.5%) | $135.63 M(+5.8%) |
Sept 2013 | - | $128.21 M(+7.3%) |
June 2013 | - | $119.43 M(+5.9%) |
Mar 2013 | - | $112.83 M(+3.6%) |
Dec 2012 | $108.93 M(+14.9%) | $108.93 M(+5.3%) |
Sept 2012 | - | $103.47 M(+2.7%) |
June 2012 | - | $100.75 M(+2.5%) |
Mar 2012 | - | $98.26 M(+3.7%) |
Dec 2011 | $94.76 M(+11.2%) | $94.76 M(+2.1%) |
Sept 2011 | - | $92.85 M(+1.9%) |
June 2011 | - | $91.13 M(+4.0%) |
Mar 2011 | - | $87.61 M(+2.8%) |
Dec 2010 | $85.19 M(+3.7%) | $85.19 M(+1.0%) |
Sept 2010 | - | $84.38 M(+5.7%) |
June 2010 | - | $79.82 M(-1.8%) |
Mar 2010 | - | $81.28 M(-1.0%) |
Dec 2009 | $82.14 M(+35.2%) | $82.14 M(+27.7%) |
Sept 2009 | - | $64.33 M(+2.9%) |
June 2009 | - | $62.54 M(+2.0%) |
Mar 2009 | - | $61.33 M(+0.9%) |
Dec 2008 | $60.76 M | $60.76 M(+2.5%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2008 | - | $59.27 M(+2.5%) |
June 2008 | - | $57.80 M(+2.3%) |
Mar 2008 | - | $56.48 M(+2.8%) |
Dec 2007 | $54.96 M(+20.8%) | $54.96 M(+4.4%) |
Sept 2007 | - | $52.62 M(+4.5%) |
June 2007 | - | $50.34 M(+5.9%) |
Mar 2007 | - | $47.55 M(+4.5%) |
Dec 2006 | $45.49 M(+20.0%) | $45.49 M(+3.5%) |
Sept 2006 | - | $43.94 M(+5.5%) |
June 2006 | - | $41.65 M(+4.9%) |
Mar 2006 | - | $39.71 M(+4.8%) |
Dec 2005 | $37.89 M(+24.8%) | $37.89 M(+2.2%) |
Sept 2005 | - | $37.06 M(+7.4%) |
June 2005 | - | $34.51 M(+8.4%) |
Mar 2005 | - | $31.84 M(+4.9%) |
Dec 2004 | $30.36 M(+68.8%) | $30.36 M(+8.9%) |
Sept 2004 | - | $27.89 M(+3.9%) |
June 2004 | - | $26.83 M(+4.1%) |
Mar 2004 | - | $25.78 M(+43.3%) |
Dec 2003 | $17.98 M(+5.4%) | $17.98 M(+4.8%) |
Sept 2003 | - | $17.15 M(+2.8%) |
June 2003 | - | $16.68 M(-0.4%) |
Mar 2003 | - | $16.75 M(-1.8%) |
Dec 2002 | $17.06 M(-15.1%) | $17.06 M(+4.0%) |
Sept 2002 | - | $16.40 M(-4.3%) |
June 2002 | - | $17.14 M(-6.3%) |
Mar 2002 | - | $18.30 M(-9.0%) |
Dec 2001 | $20.10 M(-24.7%) | $20.10 M(-2.2%) |
Sept 2001 | - | $20.56 M(-6.0%) |
June 2001 | - | $21.87 M(-10.6%) |
Mar 2001 | - | $24.47 M(-8.4%) |
Dec 2000 | $26.71 M(+3.9%) | $26.71 M(+9.9%) |
Sept 2000 | - | $24.30 M(-5.1%) |
June 2000 | - | $25.62 M(+1.2%) |
Mar 2000 | - | $25.32 M(-1.5%) |
Dec 1999 | $25.70 M(-14.0%) | $25.70 M(-12.9%) |
Sept 1999 | - | $29.50 M(+0.3%) |
June 1999 | - | $29.40 M(+3.5%) |
Mar 1999 | - | $28.40 M(-5.0%) |
Dec 1998 | $29.90 M(+14.1%) | $29.90 M(-2.9%) |
Sept 1998 | - | $30.80 M(+2.7%) |
June 1998 | - | $30.00 M(+8.7%) |
Mar 1998 | - | $27.60 M(+5.3%) |
Dec 1997 | $26.20 M(+424.0%) | $26.20 M(+344.1%) |
Sept 1997 | - | $5.90 M(0.0%) |
June 1997 | - | $5.90 M(+7.3%) |
Mar 1997 | - | $5.50 M(-12.7%) |
Dec 1996 | $5.00 M(-27.5%) | - |
Nov 1996 | - | $6.30 M(-8.7%) |
Aug 1996 | - | $6.90 M(-10.4%) |
Aug 1996 | $6.90 M(+19.0%) | - |
May 1996 | - | $7.70 M(+71.1%) |
Feb 1996 | - | $4.50 M(-16.7%) |
Nov 1995 | - | $5.40 M(-6.9%) |
Aug 1995 | $5.80 M(+7.4%) | $5.80 M(-12.1%) |
May 1995 | - | $6.60 M(+37.5%) |
Feb 1995 | - | $4.80 M(-4.0%) |
Nov 1994 | - | $5.00 M(-7.4%) |
Aug 1994 | $5.40 M(-19.4%) | $5.40 M(-8.5%) |
May 1994 | - | $5.90 M(-7.8%) |
Feb 1994 | - | $6.40 M(-3.0%) |
Nov 1993 | - | $6.60 M(-1.5%) |
Aug 1993 | $6.70 M | $6.70 M(-8.2%) |
May 1993 | - | $7.30 M |
FAQ
- What is Anika Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Anika Therapeutics?
- What is Anika Therapeutics annual shareholders equity year-on-year change?
- What is Anika Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Anika Therapeutics?
- What is Anika Therapeutics quarterly shareholders equity year-on-year change?
What is Anika Therapeutics annual stockholders equity?
The current annual shareholders equity of ANIK is $212.26 M
What is the all time high annual shareholders equity for Anika Therapeutics?
Anika Therapeutics all-time high annual stockholders equity is $288.38 M
What is Anika Therapeutics annual shareholders equity year-on-year change?
Over the past year, ANIK annual stockholders equity has changed by -$73.30 M (-25.67%)
What is Anika Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ANIK is $179.86 M
What is the all time high quarterly shareholders equity for Anika Therapeutics?
Anika Therapeutics all-time high quarterly stockholders equity is $293.69 M
What is Anika Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ANIK quarterly stockholders equity has changed by -$90.62 M (-33.50%)